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by
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Committee: Elizabeth A. Brown, Ph.D.

Objective - To explore differences in cesarean delivery and induced labor between Generation X
and Millennial women at the same age, 20-35
Method – A retrospective cohort study using the Nationwide Inpatient Sample (NIS) for the
years 2001 and 2016. Women aged 20 to 35 in 2001(Generation X) and 2016 (Millennials) were
included. OB outcome measures were compared at the same age to understand the trends in the
interventions and the characteristics of women who receive them.
Results - Millennial women compared to Generation-X women were 32% (95% CI 1.31-1.33)
more likely to have cesarean delivery, and 28 % (95% CI 1.27-1.29) more likely to have induced
labor. Furthermore, Millennial women were more likely to be older, have higher comorbidities,
severe maternal morbidity (SMM), and longer length of hospital stay.
Discussion –Millennial women have higher rates of cesarean delivery and induced labor even
after controlling for age, race, and comorbidities. The results are an indication that obstetric
interventions are routinely performed without medical indications.
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1

1.1

CHAPTER 1 INTRODUCTION

Background ad Need
About 13 percent of the roughly 4 million births that occur each year in the US result in

one or more significant complications (Glance et al., 2014). About 50,000 of the women
admitted for child delivery in the US experience SMM each year (Leonard, Main, & Carmichael,
2019; Petersen, Davis, Goodman, Cox, Syverson, et al., 2019). SMM is defined as lifethreatening childbirth complications, including maternal hemorrhage, acute congestive heart
failure, cardiac arrest, and acute myocardial infarction (Gao et al., 2019; Glance et al., 2014;
Leonard, Main, & Carmichael, 2019; Centers for disease control and prevention, 2020, January
31). The rates of maternal mortality and adverse maternal outcomes among US women are the
highest compared to women in other high-income countries despite the US spending more on
healthcare than all other developed countries (Gunja et al., 2018). The cost of delivery with
SMM diagnosis in the US is 2.1 times higher than delivery without any SMM diagnosis, $11,000
versus $4,300 (Chen et al., 2018).
Despite substantial improvements in evidence-based practices, extreme variability exists
across hospitals, races, and socioeconomic strata despite significant advances in evidence-based
practices (EBP) known to improve maternal outcomes (Glance et al., 2014). Specifically,
racial/ethnic disparities exist in SMM with non-Hispanic black women being three-five times at
a higher risk of maternal death and severe maternal morbidity than non-Hispanic white women
even after controlling for individual and hospital risk factors (Howell et al., 2018; Leonard,
Main, Scott, et al., 2019; Petersen, Davis, Goodman, Cox, Syverson, et al., 2019).
The reasons for the increase and variations in SMM are not clear. Still, a growing body of
literature attributes it to the changes in the maternal characteristics over the past few decades,
10

including increases in advanced maternal age (35 and above), obesity, comorbidities (preexisting conditions), and obstetric interventions (specifically cesarean delivery) (Leonard, Main,
& Carmichael, 2019). The rising rates of SMM and the documented racial disparities in maternal
outcomes show the need to identify tractable delivery processes affecting the quality of maternal
care provided and outcomes.
One critical strategy to improve outcomes is to understand the trends in obstetric
interventions intended to improve outcomes and the characteristics of women who receive them.
Millennial women (born between 1981 and 1996) account for 82 percent of all US
childbirths in the US (Dimock, 2019; Livingston, 2018), yet detailed analyses of their maternal
(OB) characteristics, obstetric interventions, and health outcome differences from the previous
generational cohorts is lacking. Literature suggests significant differences in generationalcohorts experiences may influence health expectations and preferences, which may influence
health outcomes (DePew, 2019; Lloyd et al., 2013).
To the best of our knowledge, literature is limited that compares generational-specific
health outcomes. Our literature review identified one study by DePew (2019) that examined
health outcome differences (self-reported mental, physical, and functional status) between
Millennials and Generation X by using the data from the National Health Interview Survey
(NHIS). However, the study did not specifically examine women or maternal outcomes.
The primary objective of this study is to compare obstetric outcomes and the use of
cesarean delivery and induction of labor for Millennial (born 1981-1996) and Generation X
women (born 1965-1980) at the same age (20-35) to understand the trends in the interventions
and the characteristics of women who receive them.
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Without fully understanding the maternal health characteristics and outcomes of specific
populations, it is challenging to plan and prioritize resources necessary to improve maternal
outcomes.

1.2

Problem Statement
Severe maternal morbidity has increased by more than 200%, primarily driven by

maternal hemorrhage, from 49.5 in 1993 to 144.0 in 2014 (Centers for disease control and
prevention, 2020, January 31). During this same period, between 1990 and 2015, cesarean
delivery and induction of labor increased by 41% and 159%, respectively (Teitler et al., 2019).
Studies show no evidence of increased use of cesarean delivery or induction of labor and
decreased maternal and neonatal morbidity (Hamilton et al., 2013; Martin et al., 2019). The trend
may signify a possible increase in the number of cesarean deliveries and induced labor
performed without any medical indication. Our study will compare maternal outcome measures
to understand trends in the interventions and the characteristics of women who receive them.

1.3

Study Objective and Hypotheses
The primary objective of the study is to describe differences in risk (chronic health

condition), OB process (use of cesarean and induction of labor), and outcomes for Millennial and
Gen-X women in the same age span (20-35 years). Outcomes to be assessed include:
•

Differences in the presence of maternal risk factors

•

Differences in the use of cesarean delivery and induction of labor

•

Differences of adverse obstetrical outcomes defined by CDC indicators
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•

Variations in length of stay (LOS), cost of admission (adjusted for inflation), and
discharge destination.

1.4

Null Hypothesis
There are no differences in maternal risk factors, uses of cesarean sections and induction of

labor, morbidity (defined by CDC indicators), length of stay, and cost of admission (adjusted for
inflation) between Millennial and Generation X women at the same age (20-35).

1.5

Alternative Hypothesis
Millennial women compared to Generation X women at the same age (20-35) have higher

maternal risk factors, use of cesarean delivery and induced labor, morbidity (defined by CDC
indicators), hospital length of stay, and total cost of admission (adjusted for inflation).

1.6

Population and Analysis
The study population was drawn from the Nationwide Inpatient Sample (NIS) of the

Healthcare Cost and Utilization Project (HCUP) databases, outsourced from the Medical
University of South Carolina Research Center. The NIS is an all-payer nation-wide database that
contains a 20% sample of all hospitalizations in the US. The sample included all women aged
20-35 in 2001 and 2016 who had child delivery hospitalizations, regardless of the outcome.
Deliveries for women under 20 years old and over 35 years-old will be excluded because both
maternal age extremes are independent risk factors for adverse maternal outcomes (Walker et al.,
2020).
The SAS version 9.4 analytical software was used to analyze the data to compare
sociodemographic, preexisting medical conditions, indications, and outcomes of IOL and
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cesarean delivery. Descriptive statistics tools were used to summarize the data, including
frequency, percentage, mean, odds ratio, standard deviation, and cross-tabulations, to examine
differences between group variables.
All continuous variables were tested by Wilcoxon- Mann-U test. Categorical variables
were tested using the Chi-square to explore the significance of any variations in results. The
Charlson Comorbidity Index was used to categorize and compare patients' comorbidities and
clinical variables.

14

2

CHAPTER II: LITERATURE REVIEW

The US has the highest rate of severe maternal morbidity (SMM) and maternal deaths
from pregnancy complications among developed countries (Callaghan et al., 2012; Collier &
Molina, 2019; Gunja et al., 2018; Wang et al., 2020). SMM comprises life-threatening
conditions, including acute myocardial infarction, cardiac arrest, or sepsis/shock, which if not
quickly identified and treated may result in maternal death (Firoz et al., 2013; Gao et al., 2019;
Geller et al., 2002; Gunja et al., 2018; Wilson & Salihu, 2007).
SMM increased by more than 200% in 10 years, from 49.5 in 1993 to 144.0 in 2014,
driven by a substantial increase in blood transfusion between 1993 and 2014, from 24.5 in 1993
to 122.3 in 2014 (Centers for disease control and prevention, 2020, January 31). Without blood
transfusions, the rate of SMM increased by about 20% from 28.6 in 1993 to 35.0 in 2014
(Centers for disease control and prevention, 2020, January 31).
Significant racial/ethnic disparities in pregnancy outcomes exist, with non-Hispanic black
women having a 4-5 times higher prevalence of SMM than non-Hispanic white women even
after controlling for individual comorbidity factors (Leonard, Main, Scott, et al., 2019).
The reasons for the rise and racial disparities have not been fully explored (Metcalfe et al.,
2018). A growing body of evidence points to the changes in the risk profiles of women becoming
pregnant, including delayed motherhood, increases in obesity, chronic diseases (hypertension,
diabetes, and heart diseases), and rates of cesarean deliveries (Gunja et al., 2018; King, 2012).
As the Millennial generation women (those born between 1981-1996) now account for
the vast majority of all US childbirths (Livingston, 2018; White &Wurn, 2009), there is an
urgent need to explore maternal health characteristics specific to this generation to recognize
potential trends and opportunities for improvement.
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This literature review uses multiple sources to provide an overview of the current
evidence on the characteristics of pregnant women that are associated with pregnancy-related
adverse outcomes and interventions.

2.1

Millennial Generation
The Millennial generation, also known as Generation Y (Gen Y) or Millennials,

comprises those born between 1981 and 1996 (Dimock, 2019). They come after Generation X
(those born between 1965 and 1980). Millennials number approximately 73 million compared to
Boomers (71.6 million) and Generation X (65.2) million “American Community Survey: 20092013.”; Fry, April 28, 2020).
Millennials are different from other generations in so many ways. Some of the
differences in the characteristics of Millennials and Generation X are listed in table 1 below.
The differences between generations give us a unique view of how generational life experiences
influence specific behaviors.
Millennials are more educated and racially/ethnically diverse than previous generations,
with 44.2 percent belonging to a minority race or ethnic group and highly educated (US Bureau
of Census, July 25, 2015). DePew (2019) found 31.9% of Millennials have a bachelor’s degree
compared to 23.4% of Generation X.
Similarly, a US Census Bureau survey found 22 percent of Millennials (18-34 years)
have a college degree compared to 16 percent for Generation X, one in four Millennials (17.9
million) speaks a foreign language at home, one in five (13.5 million) millennials live in poverty
compared to 8.4 million Generation X, and about three in 10 Millennials were marries compared
to six in 10 Generation X (“American Community Survey: 2009-2013.”)
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Millennials are the first generation to grow up in an environment with rapid growth in
digital information technology and social media, providing them with easy access to health
information (Lloyd et al., 2013). It is unclear how Millennials' greater access to digital
technology and health information influences their health care preferences and health outcomes.
However, literature shows an association between greater access to digital technology with
sedentary lifestyles, feelings of social isolation, anxiety, and depression among Millennials
(DePew, 2019).

Table 1 Selected Characteristics Differences Between Millennials and Generation Xers
Characteristic

Millennials
Born 1981-1996
~73 million

Generation X
Born 1965-1980
~65 MILLION

Education attainment ≥ Bachelor’s
Degree (DePew, 2019)
(Age 20-35 years)
Health insurance status
(DePew, 2019)
(Age 20-35 years)

31.9%

23.4%

13.5% uninsured
18.9 public insurance
64.0% Private insurance

23.2% uninsured
5.8% of public insurance
69.0% Private insurance

Already mom at the age of 20 to 35
(White &Wurn, 2009).

48 percent (in 2016) –
Delaying motherhood.

57 percent (in 2000)

Marital Status
(“American Community Survey:
2009-2013.”)

3/10 married between 1834 years

6/10 married between 1834 years.

Total population (Fry, 2020)

Millennials are also changing the way health care is delivered. The vast majority of
millennials prefer "on-demand" health care delivery options like Urgent Cares, clinics, and
telemedicine rather than going to a primary care physician for their health care (Milne, 2019).
About 50% of Millennials,18-29-year-old, report not having a primary care physician to manage
their health care needs, raising concerns about potential delays in catching severe medical
problems before they become critical (Milne, 2019). A growing body of evidence now shows
17

millennials are in poorer health than previous generations, with their health declining faster than
previous generations (White &Wurn, 2019).
Millennials have a higher prevalence of hypertension, high cholesterol, tobacco use
disorder, and behavioral health problems (major depression and hyperactivity) than previous
generations (White &Wurn, 2019). Millennials' maternal health patterns reveal a worrisome
trend of delayed motherhood, with the mean average age at first pregnancy of 26.3 (rising from
24.9 years in 2000 to 26.3 years in 2014) (Mathews & Hamilton, 2016).
Only 48 percent of Millennials at the age of 20 to 35 in 2016 were already moms
compared to 57 percent of Generation X women (those born between 1965 and 1980) who were
already moms at the same age in 2000 (Mathews & Hamilton, 2016).
The combination of poor health characteristics and delayed motherhood for Millennials
raises concerns about worsening maternal health outcomes, as advanced maternal age and poor
maternal characteristics are associated with increased risk of adverse maternal outcomes
(Kortekaas et al., 2020; Lipkind et al., 2019).

2.2

Maternal Mortality
Maternal mortality is any death of a woman (other than accidental) that occurs while a

woman is still pregnant or within 42 days of the end of pregnancy, regardless of the duration or
site of the pregnant occur during pregnancy (Centers for disease control and prevention, 2020,
February 20).
Pregnancy-related death is any death of a woman (other than accidental) that occurs
while the woman is pregnant or within one year of the end of pregnancy, regardless of the
duration or site of the pregnancy (Centers for disease control and prevention, 2020, February 20).
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In the US, the CDC is the primary source of maternal death/mortality data. The data is
housed in the two national systems, the National Vital Statistics System (NVSS) and the
Pregnancy Mortality Surveillance System (PMSS) (Collier & Molina, 2019). All 50 states,
including the District of Columbia and New York City, voluntarily submit maternal death
certificates linked with fetal birth or death certificates for all pregnant women who died while
pregnant or within a year of termination of pregnancy (Chang et al., 2003; Creanga et al., 2017;
Petersen, Davis, Goodman, Cox, Mayes, et al., 2019).
Epidemiologists then analyze the data to determine the cause and timing of death, which
is then used to generate pregnancy-related mortality surveillance reports. For this study,
pregnancy-related death, maternal mortality, and maternal death will be used synonymously.

2.3

Maternal Mortality Trends
Between 1987 and 2017, the maternal mortality ratio (defined as deaths per 100,000

livebirth deliveries) in the US more than doubled - from 7.2 deaths per 100,000 live births in
1987 to about 17.2 deaths per 100,000 live births in 2015 (Hoyert, 2007; (Petersen, Davis,
Goodman, Cox, Mayes, et al., 2019). Literature credits the implementation of the Pregnancy
Mortality Surveillance System (PMSS) in 1986 to the improved identification of maternal deaths
and the collection of information about the causes and risk factors associated with maternal
mortality (Petersen, Davis, Goodman, Cox, Mayes, et al., 2019).
Table 2 list the top 10 leading causes of maternal deaths, based on the CDC criteria,
which include cardiovascular diseases, non-cardiovascular medical conditions, infection
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(12.5%), cardiomyopathy (11.0%), and hemorrhage (11.0%), (Centers for disease control and
prevention, 2020, February 20).

Table 2. Top 10 Causes of Maternal Mortality in the US
Cause of Maternal Mortality

Rate (%)

Cardiovascular diseases

15.7%

Non-cardiovascular medical conditions

13.9%

Infection

12.5%

Cardiomyopathy

11.0%

Hemorrhage

11.0%

Thrombotic pulmonary/embolism

9.0%

Cerebrovascular accidents

7.7%

Hypertensive disorders of pregnancy

6.9%

Unknown

6.4%

Amniotic fluid embolism

5.6%

The timing of maternal deaths varies, with 31.3% of the maternal mortality occurring
during pregnancy, 16.9% during delivery, 18.6% 1-6 days after delivery, 21.4% 7-42 days after
delivery, and 11.7% 43-365 days after delivery (Petersen, Davis, Goodman, Cox, Mayes, et al.,
2019). Maternal hemorrhage and amniotic fluid embolism cause the most deaths at delivery,
high blood pressure disorders, postpartum hemorrhage, and infection cause the most death from
postnatal day 1 to one week postpartum, and cardiomyopathy and cardiovascular disease are the
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leading causes of maternal death from1 week to 1 year postpartum (Centers for disease control
and prevention, 2020, May).
Growing evidence shows that 60 percent of all maternal deaths are preventable
("Pregnancy-related deaths," 2020). Multiple factors contribute to maternal mortality, including
patient, provider, or system-related (Petersen, Davis, Goodman, Cox, Mayes, et al., 2019).

2.4

Severe Maternal Morbidity
In addition to increased maternal deaths, the US is experiencing increased rates of SMM

(defined as unexpected pregnancy outcomes that negatively impact the woman's health long or
short term) (Firoz et al., 2013). Severe maternal morbidity is 50 to 100 times more prevalent than
maternal death, and disproportionately affect minority women in the United States (Liese et al.,
2019).
Between 1993 - 2014, severe maternal morbidity increased by 200% (driven by maternal
hemorrhage), from 49.5 in 1993 to 144.0 in 2014 (Centers for disease control and prevention,
2020, January 31). After excluding blood transfusion, the increase was 20% over time from 28.6
in 1993 to 35.0 in 2014 (Centers for disease control and prevention, 2020, January 31). SMM
related to hemorrhage increased by 399%, acute renal failure 300%, adult respiratory distress
syndrome 205%, cardiac arrest, fibrillation, or conversion of cardiac rhythm by 175%, shock at
173%, acute myocardial infarction or aneurysm 100%, ventilation/temporary tracheostomy at
93%, Sepsis at 75%, and hysterectomy at 55 (Centers for disease control and prevention, 2020,
January 31).
Despite SMM being 50 to 100 times more prevalent than maternal death, it is not
routinely studies leading to a lack of better understanding of the specific causes. The CDC
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(2020) currently uses 21 (Table 3) indicators to identify and track SMM. If not quickly identified
and treated, these conditions may result in maternal death (Firoz et al., 2013; Gao et al., 2019;
Geller et al., 2002; Gunja et al., 2018; Wilson & Salihu, 2007).

Table 3. 21 CDC indicators to identify severe maternal morbidity
Acute myocardial
infarction
Adult respiratory distress
syndrome
Conversion of cardiac
rhythm
Heart failure/arrest during
surgery or procedure
Severe anesthesia
complications
Sickle cell disease with
crisis
Hysterectomy

2.5

Aneurysm

Acute renal failure

Amniotic fluid
embolism
Disseminated
intravascular
coagulation (DIC)
Puerperal
cerebrovascular
disorders
Sepsis

Cardiac arrest/ventricular
fibrillation
Eclampsia

Air and thrombotic
embolism
Temporary
tracheostomy

Blood products
transfusion
Ventilation

Pulmonary edema / acute
heart failure
Shock

Maternal Characteristics and Outcomes
Maternal mortality and morbidity vary substantially by race/ethnicity, maternal age,

education, income, geographic location, hospital type, and pre-existing chronic conditions
(Howland et al., 2019; Leonard, Main, Scott, et al., 2019; Liese et al., 2019; Main et al., 2020;
Metcalfe et al., 2018; Petersen, Davis, Goodman, Cox, Syverson, et al., 2019). The involvement
of multiple factors causing SMM provides valuable insight into the complexity of preventing
severe maternal morbidity and mortality in the US.
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2.5.1

Race/Ethnicity
The trend in the increase in maternal mortality and morbidity in the US over the past

three decades has not been consistent across all racial groups (Metcalfe et al., 2018). Racial and
ethnic minority groups have consistently been associated with higher maternal mortality and
morbidity rates than non-Hispanic white women, raising concerns about variations in care related
to structural racism (Chang et al., 2003; Fingar et al., 2006; Howland et al., 2019; Leonard,
Main, Scott, et al., 2019; Liese et al., 2019; Wang et al., 2020). The disparities in maternal
outcomes are more significant on non-Hispanic black women even after controlling for all other
factors.
Literature shows that non-Hispanic black women fare poorly in all SMM indicators used
by the CDC to measure outcomes, including rates of blood transfusion, DIC, heart failure,
hysterectomy, acute respiratory distress syndrome, ventilation, acute renal failure, eclampsia,
shock, and sepsis even after adjusting for confounders (Admon et al., 2018; Fingar et al., 2006;
Liese et al., 2019)
Similarly, maternal mortality for non-Hispanic black women is consistently ranked
higher (three-to-four times) than that for non-Hispanic white women even after controlling for
comorbidities or chronic medical conditions (Admon et al., 2018; Berg et al., 1996; Berg et al.,
2010; Chang et al., 2003; Creanga et al., 2015; Mogos et al., 2020; Petersen, Davis, Goodman,
Cox, Syverson, et al., 2019).
The most common underlying causes of maternal mortality among non-Hispanic black
women include preeclampsia, eclampsia, and embolism (Collier & Molina, 2019). Preeclampsia
is a potentially fatal maternal condition marked by the new onset of high blood pressure after 20
weeks' gestation, accompanied by proteinuria or significant end-organ dysfunction, whereas
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eclampsia encompasses pregnancy-induced hypertension with the development of grand mal
seizures (Bernardes et al., 2019; Dekker, 2014; Haroon et al., 2019; Heard et al., 2004; Wen et
al., 2019).
Non-Hispanic black women are at a higher risk of ectopic pregnancy (8%) than white
women (4%) (Chang et al., 2003), and are six times more likely to die from cardiomyopathy and
complications of anesthesia (Berg et al., 1996; Chang et al., 2003).
The variability in outcomes by race is further proof that more can be done to narrow the
gap and improve outcomes for all women.

2.5.2

Maternal Age
Similar to race, maternal age has consistently been found to be an independent risk factor

for adverse maternal outcomes, including gestational diabetes, preeclampsia, placenta previa,
low birth weight (less than 2500 g), and preterm births (Cavazos-Rehg et al., 2015; Walker et al.,
2020).
Between 2000 and 2017, the rate of women under 25-years-old giving birth declined,
whereas those above 25 years old have increased (Anne et al.). There has been an increase in the
percentage of births from women aged 25-29 (26.8% to 29.1%), women aged 30–34 (22.9% to
28.3%), and women aged 35–39 (11.1% to 14.4%) (Anne et al.).
Advanced maternal age (35 years and above) is associated with higher obstetric
intervention rates, increases in hypertensive disorders, placenta abruption, and perinatal death
even after controlling for other patient and non-patient factors (Dublin et al., 2014; Kean et al.,
2020).
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Maternal age distribution affects the outcomes of the same conditions differently. Walker
et al. (2020) compared the results of women under 20 years old with those between 35-39 years
old. They found women under 20 years-old with diabetes mellitus experienced higher rates of
preeclampsia, large for gestation babies, and lower rates of cesarean delivery. In contrast, women
aged 35-39 years with diabetes experienced higher rates of intrauterine fetal demise (IUFD),
cesarean births, and lower rates of large for gestation babies (Walker et al., 2020).

2.5.3

Payer Type/Insurance Coverage
The association between insurance type or coverage with maternal outcomes has been

widely researched. A systematic review by Wang et al.,(2020) found 21 studies, which found
insurance coverage was a predictor of maternal outcomes with better results associated with
private/commercial insurance coverage. In contrast, women with Medicaid or no insurance
coverage were at a higher risk for adverse maternal outcomes, including deaths from
cardiovascular, respiratory, and sepsis-related conditions (Wang et al., 2020).

2.5.4

Other Social Determinants
Several other social determinants affect maternal outcomes. For example, women with

lower levels of education, low income, unmarried, and those admitted to urban teaching
hospitals, or living in the Southern states are associated with a higher risk of maternal mortality
and morbidity (Acosta et al., 2013; Collier & Molina, 2019; Goffman et al., 2007; Kozhimannil
et al., 2019; Kuriya et al., 2016). Evidence, however, shows that the risks for non-Hispanic black
women are not mitigated by education

25

2.6

Obstetric Interventions
The prevalence of adverse obstetric outcomes varies by timing relative to the end of

pregnancy, with most complications occurring towards the end of pregnancy ("Levels of
Maternal Care: Obstetric Care Consensus No, 9 Summary," 2019; Middleton et al., 2018).
Obstetric interventions to prevent adverse outcomes towards the end of pregnancy
include practices of planned delivery by induction of labor (artificial stimulation of labor before
the natural onset) and Cesarean delivery (Ananth et al., 2013; Loktionov et al., 2019; Marconi,
2019; Tsakiridis et al., 2020). Induction of labor and cesarean delivery accounts for more than
25% of all US births (Ananth et al., 2013; Obstetrics, 2009; Teitler et al., 2019).
Between 1990 and 2015, cesarean deliveries and labor induction increased substantially
in full term-pregnancies by 41% and 159%, respectively (Teitler et al., 2019). While both
cesarean delivery and induction of labor were previously performed for medical reasons, the
practices are now routinely performed without any medical indications raising concerns about
their contribution to a rise in SMM (Ananth et al., 2013; Marconi, 2019; Souter et al., 2019).

2.6.1

Induction of Labor (IOL)
IOL is the artificial stimulation of uterine contractions before the spontaneous or natural

onset of labor (Hersh, Skeith, Sargent, & Caughey, 2019). IOL has been on the rise in the US
since the 1990s, and nearly tripled between 1990 and 2018, from 9.5 percent in 1990 to 27.1
percent in 2018 (Martin et al., 2019)).
There are ongoing controversies regarding the association between IOL and increased
rates of cesarean delivery, which stem from observation studies that erroneously compared
outcomes of induction of labor with spontaneous delivery, instead of IOL versus expectant
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management (Caughey et al., 2009). These controversies are widely documented elsewhere
(Marconi, 2019) and will not be the focus of this review.
However, overwhelming consensus exists regarding the benefits of IOL when expectant
management possess a higher risk to maternal and fetal outcomes than to early termination of
pregnancy via IOL (Ananth, Wilcox, & Gyamfi-Bannerman, 2013; Wilson, 2007).

2.6.2

IOL Indications
The top five indications of labor induction included gestation age greater or equal 41

completed weeks (23.2%), premature rupture of membranes (18.1%), gestation hypertension or
preeclampsia (19.2%), diabetes (pre-existing or gestation) (10.0%), and oligohydramnios (low
amniotic fluid volume) (7.0%) (Dublin et al., 2014).

2.6.3

Guidelines for IOL
The leading maternal health professional societies, the American College of Obstetricians

and Gynecologists (ACOG), the Society of Obstetricians and Gynecologists of Canada (SOGC),
the National Institute for Health and Care Excellence (NICE), and the World Health
Organization (WHO) all have different guidelines for IOL to guide providers (Tsakiridis et al.,
2020).
The ACOG indications of IOL include placenta abruption, chorioamnionitis, gestational
hypertension, preeclampsia, eclampsia, post-term pregnancy, premature rupture of membranes,
maternal medical conditions, fetal compromise, fetal demise, and logistic reasons at term such as
distance from the hospital (Tsakiridis et al., 2020).
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2.6.4

Elective IOL
Induction of labor is now increasingly performed without clinical indications, especially

among term primiparas women delivering singleton infants (Ananth et al., 2013). IOL is not
recommended before 39 weeks because it is associated with adverse maternal outcomes (Sgayer
& Frank Wolf, 2019). The factors associated with elective IOL, include patient and provider
convenience, external pressure or influence (peers), financial incentives, and technology (Moore
& Low, 2012).

2.6.5

Comparative Evidence of Induction of Labor vs. Expectant Management
The timing of delivery is critical to preventing perinatal complications and maternal

morbidity (Lee et al., 2016). To mitigate for adverse outcomes associated with advanced
gestational age and variations in maternal care, health experts are increasingly pushing for
widespread adoptions of policies that support routine induction of labor at term gestation and
beyond (Akinsipe et al., 2012; Levine et al., 2019). Several studies now attribute IOL in low-risk
singleton pregnancies at term and beyond with decreased risks of cesarean delivery or perinatal
adverse events, and reduced risk of gestational hypertensive diseases (Caughey et al., 2009;
Saccone et al., 2019; Sotiriadis et al., 2019).
Elective induction of labor, when compared to expectant management, reveals improved
outcomes (Table 4). Elective induction is associated with decreased pregnancy-related
hypertension in nulliparous (2.2% vs. 7.3%) and multiparous women (0.9% vs. 3.5%) (Souter et
al., 2019) and less frequent severe maternal morbid (5.6% vs. 7.6%), less common cesarean
delivery (35.9% vs. 41.0%), and less neonatal intensive care unit admission ( 7.9% vs. 10.1%) in
obese women (Gibbs Pickens et al., 2018).
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Table 4 Outcomes of elective induction of labor vs. expectant management
Study/Title

Population

Design

Findings/Conclusion

(Souter et al., 2019)

Singleton cephalic
hospital births at
39+0-42+6 weeks
gestation

Compares outcomes for electively
induced births at ≥39 weeks' gestation
with expectant management using
abstracted chart data from 21 hospitals
in Northwest U.S., January 1, 2012 –
December 31, 2017, N = 55,694

(Gibbs Pickens et al.,
2018)
Term elective induction
of labor and pregnancy
outcomes among obese
women and their
offspring

Singleton, cephalic,
nonanomalous
deliveries to obese
women gestational
week (39-41), N =
165,975

Retrospective cohort study, 20072011, of California linked patient
discharged data compared termelective induction of labor between 39
- 41 weeks of gestation and pregnancy
outcomes among obese women.

(Grobman & Caughey,
2019; Grobman et al.,
2018)
Labor Induction versus
Expectant Management
in Low-Risk
Nulliparous Women

Women at 38 weeks 0
days to 38 weeks 6
days of gestation to
labor induction at 39
weeks 0 days to 39
weeks 4 days or
expectant
management

Multicenter randomized trial of labor
induction in low-risk nulliparous
women. N= 3062 women assigned to
induction of labor; N=3044 to
expectant management

Elective induction is
associated with a decreased
risk of cesarean delivery
(14.7% vs. 23.2%). Elective
induction is associated with
decreased pregnancy-related
hypertension in nulliparous
(2.2% vs. 7.3%) and
multiparous women (0.9%
vs. 3.5%
Elective labor induction after
39 weeks of gestation was
associated with reduced
adverse outcomes among
obese women. Induced
obese nulliparous women
had less frequent severe
maternal morbid, 5.6% vs.
7.6%; less common cesarean
delivery, 35.9% vs. 41.0%,
less neonatal intensive care
unit admission, 7.9% vs.
10.1%.
Induction of labor at 39
weeks resulted in
significantly lower rates of
cesarean delivery, and
similar or slightly better
outcomes.

(Darney et al., 2013)

All deliveries at 37-40
weeks without prior
cesarean delivery in
California, 2006.

A retrospective cohort study.
Compared elective induction at each
term gestational age (37-40 weeks)
with expectant management using
2006 California Department of Health
Service linked birth data. N= 362,154.

Elective induction was
associated with decreased
odds of cesarean delivery
across all gestation ages and
parity (37-40 weeks, OR
0.44, 0.43, OR 0.46, and
0.57, respectively.)

Women with singleton
pregnancies at 37
weeks or more
gestation

Retrospective cohort study compared
maternal and neonatal outcomes in
pregnancies of 37 weeks or more.
N=1,271,549.

Elective induction of labor at
each gestation week is
associated with decreased
risk of perinatal mortality
compared to expectant
management in women with
singleton pregnancies.

Maternal and newborn
outcomes with elective
induction of labor at
term

Elective induction of
labor at term compared
with expectant
management: maternal
and neonatal outcomes.
(Stock et al., 2012)
Outcomes of elective
induction of labor
compared with
expectant management:
a population-based
study.
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2.6.6

Policies of routine Induction of Labor
Multiple studies, as illustrated in Table 5, have linked routine induction of labor with

fewer perinatal deaths, reduced cesarean deliveries, lower NICU admissions, and fewer babies
with low Apgar scores (Cluver et al., 2017; Loktionov et al., 2019; Marrs et al., 2019; Middleton
et al., 2018). Our study will explore the women characteristics associated with this potentially
lifesaving intervention.

Table 5. Policies of routine induction of labor and outcomes
Study/Title

Population

Design

Findings/Conclusion

(Loktionov et al.,
2019)
Does an elective
induction policy
negatively impact
on vaginal
delivery rates?

A retrospective review of
women undergoing
induction of labor

Assess the influence of a policy
of routine induction of labor on
cesarean delivery rates and
vaginal delivery. N=583

(Middleton et al.,
2018)
Induction of labor
for improving
birth outcomes
for women at or
beyond- term

30 Randomized controlled
trials in pregnant women at
or beyond-term.

Assessed the effects of a policy
of labor induction versus
expectant management. N =
12,479 women.

There was no association
between elective induction of
labor and increased risk of
cesarean delivery or operative
vaginal delivery in patients less
than 35 years of age.
Statistically difference in
operative vaginal delivery vs.
vaginal delivery existed between
women ≥ 35-year-old and < 35year-old groups.
A policy of labor induction is
associated with fewer perinatal
deaths, reduced cesarean
deliveries, lower NICU
admissions, fewer babies with
low Apgar scores, but with more
operative vaginal births.

(Cluver et al.,
2017)
Planned early
delivery versus
expectant
management for
hypertensive
disorders from 34
weeks’ gestation
to term

Five Randomized trials of
policies of planned early
delivery for women with
hypertensive disorders from
34 weeks’ gestation.

Cochrane systematic review:
Assessment of the benefits and
risks of a policy of elective
induction of labor versus a
policy of expectant
management. N=1,819.
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Induction of labor after 34
weeks is associated with
decreased risk of composite
maternal morbidity and
mortality in women with
gestational hypertension/mild
preeclampsia and no significant
difference in neonatal outcomes.

2.7

Cesarean Delivery
Cesarean delivery (Cesarean section or Cesarean birth) is a common obstetrical

intervention that has been rising worldwide since the 1990s and now accounts for one-third of all
the births in the US (Martin et al., 2019). Significant variation exists in the rate of cesarean by
across states, hospitals, and among low-risk women (Gynecologists & Medicine, 2014).

2.7.1

Indications:
Cesarean delivery is either medically indicated or electively indicated related to the

maternal request or provider preference. The top three indications of primary cesarean delivery
account for 80 percent of the deliveries. These reasons include labor arrest (failure to progress),
nonreassuring fetal heart tracing, and fetal malpresentation (Boyle et al., 2013). Additional
indications of cesarean delivery include uterine rupture, placenta previa, placenta accreta,
umbilical cord prolapse, chorioamnionitis (maternal infection), suspected macrosomia, a prior
cesarean delivery (Gynecologists & Medicine, 2014).

2.7.2

Complications and morbidity
While cesarean delivery can be lifesaving in certain instances, evidence shows that

cesarean delivery in low-risk pregnancies is a risk factor for severe maternal morbidly (Clark et
al., 2008; Leonard, Main, & Carmichael, 2019). Further, evidence reveals the increase in
obstetric interventions shows no corresponding evidence of decreasing maternal and neonatal
morbidity (Hamilton et al., 2013; Martin et al., 2019).
The risk factors for cesarean delivery morbidity include maternal age >30 years, minority
race/ethnicity, the existence of pre-existing medical conditions, and type of delivery hospital
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(urban, teaching, or larger hospitals) (Creanga et al., 2015). Also, emergent cesarean deliveries
are associated with higher risks of maternal and neonatal morbidity.

2.8
2.8.1

Characteristics Associated with Cesarean Delivery
Age
Advanced maternal age is linked to increased pre-pregnancy risk factors that may impact

pregnancy outcomes and increase the risk of cesarean delivery. A large Danish population-based
study (Rydahl et al., 2019) examined the association between advanced maternal age and risk for
the cesarean section using maternal age less than 30 years as a reference and found a strong
positive association between age and cesarean delivery. Nulliparous women aged 35-39 had
twice the risk, whereas those over 40 years had triple the threat for cesarean delivery (Rydahl et
al., 2019).

2.8.2

Insurance Coverage
A systematic review and meta-analysis of 16 studies involving about 9 million women in

the US compared the odds of cesarean sections of uninsured women versus insured women. We
found lower odds (0.7) of cesarean sections among uninsured women compared to women with
private insurance coverage (Hoxha et al., 2019).
A similar study found that cesarean sections were 1.13 higher among women with private
health insurance coverage than women with public insurance coverage, an indication that
financial incentives associated with private insurance encourage providers to perform more
cesarean deliveries (Hoxha, Syrogiannouli, Braha, et al., 2017).
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Regardless of risk factors, the odds of cesarean deliveries are 1.41 times higher in forprofit hospitals than in non-profit hospitals (Hoxha, Syrogiannouli, Luta, et al., 2017).

2.8.3

Race/Ethnicity

The race/ethnicity is also associated with IOL, with 61.1% of non-Hispanic white women
more likely to have elective induction than Hispanic women (15.3%) and black women (8.7%)
and indicating of the influence of non-patient factors (Hoxha et al., 2019).
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3.1

CHAPTER III METHODOLOGY

Research Design
A retrospective analysis of hospitalization archival data from the Nationwide Inpatient

Sample (NIS) database of the Healthcare Cost and Utilization Project (HCUP) on women aged
20-35 years old in 2001 and 2016 was conducted.
The primary objective of the study was to explore differences in the presence of maternal risk
factors, uses of cesarean sections and induction of labor, adverse maternal outcomes (defined by
CDC indicators), length of hospital stay, cost of admission (adjusted for inflation), and discharge
destination between Millennial and Generation X women in the same age span (20-35).

3.2

Study Population
The population studied included all women aged 20-35 who had child delivery

hospitalizations in 2001 and 2016, regardless of the pregnancy outcome. Deliveries for women
under 20 years old and over 35 years old will be excluded because they are independent risk
factors for adverse maternal outcomes (Walker et al., 2020).

3.3

Data Source
The population-based data for analysis were obtained from the Nationwide Inpatient

Sample (NIS) database of the Healthcare Cost and Utilization Project (HCUP) outsourced from
the Medical University of South Carolina Research Center.
The NIS database is an all-payer national hospital database sponsored by the Agency for
Healthcare Research and Quality (AHRQ). It contains a 20% stratified sample of all US hospital
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discharges (Nationwide Inpatient Sample, December 2019). The NIS is the only national
database with discharge records for all patients, regardless of the payer type (Kozhimannil et al.,
2013).

3.4

Data Set Description
The study used the 2001 and 2016 population-based data from the National Inpatient

Sample (NIS) database of the Healthcare Cost and Utilization Project (HCUP). The NIS data is
de-identified and comprises information related to the population demographics, diagnoses,
procedures, and hospital characteristics (Nationwide Inpatient Sample, December 2019).
The database is the only nationally available database in the US that includes all
discharges, regardless of the payer. It is audited annually before release to ensure high quality
and validity (Metcalfe et al., 2018). The NIS data is de-identified, with each record containing
various information, including patient demographics, diagnoses, and hospital characteristics
(Nationwide Inpatient Sample, December 2019).
The data set is widely used in health services research, including in maternal health
research, to explore national trends in healthcare utilization, quality, and outcome (Kozhimannil
et al., 2019; Kozhimannil et al., 2013).

3.5

Independent and Dependent Variables
The operational definition of variables was based on the descriptions by the National

Inpatient Sample (NIS) data in HCUP (Nationwide Inpatient Sample, December 2019).
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The description of variables (covariates) was based on the HCUP descriptions available on the
HCUP website, https://www.hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp.

3.6

Covariates
The covariates (independent variables) used to compare outcomes included age,

race/ethnicity, Charlson Comorbidity Index, primary payor type, length of stay, the total cost in
dollars.
a. Age: Age in years (AGE) is calculated from the birth date (DOB or reported age at
admission and is described as follows in HCUP data
b. Race/ethnicity: The race of the patient is coded based on information provided by the
source. For our study, the race categories were limited to for types: White, Black,
Hispanic, and Other. The “other group” encompassed all races (values 4-B) that were not
White, Black, or Hispanic.
Variable Description

Value

Value Description

RACE

1

White

2

Black

3

Hispanic

4

Asian or Pacific Islander

5

Native American

6

Other

.

Missing

.A

Invalid

.B

Unavailable from source (coded in 1988-1997 data
only)

Race

Source: www.hcup-us.ahrq.gov
c. Payor type: Payor indicates the expected primary payor (Medicare, Medicaid, private
insurance, etc.) as provided by the source. For our study, payor was limited to Medicare,
Medicaid, Private insurance, and Self-pay. We did not account for the uninsured.
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Variable

Description

Value

PAY1

Expected primary 1
payer, uniform
2

Value Description
Medicare
Medicaid

3

Private insurance

4

Self-pay

5

No charge

6

Other

.

Missing

.A

Invalid

.B

Unavailable from source (coded in 1988-1997 data
only)

Source: www.hcup-us.ahrq.gov

d. Length of stay is the difference between the discharge date and the admission date

Variable
LOS

Description

Value

Value Description

Length of stay,
cleaned

0 - 365 (for
HCUP
inpatient
data), 0-30
(for HCUP
outpatient
data)

Days (Prior to the data year 2017, LOS was
limited to 0-3 days for outpatient data. In the
1988-1997 inpatient data, LOS can be greater than
365 days)

.

Missing

.A

Invalid

.B

Unavailable from source (coded in 1988-1997
data only)

.C

Inconsistent: beginning with 1998 data, ELOS03,
ELOS04; in 1988-1997 data, ED011, ED601,
ED911n, ED921

Source: HCUP

e. The total cost of hospitalization- Costs was weighted for Generation X patients by
multiplying total costs by a factor of 1.7
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f. Charlson Comorbidity Index score- was based on the coding of the presence or
absence of eligible conditions.

3.7

Outcomes Variable
The outcomes of interest include differences in maternal risk factors, use of cesarean

sections and induction of labor delivery methods, adverse obstetrical outcomes defined by CDC
indicators, length of stay (LOS), cost of admission (adjusted for inflation), and discharge
destination.
Adverse maternal outcomes were based on the presence of ICD codes for conditions
defined by the CDC using the 21 CDC indicators, including hemorrhage with blood transfusion,
infection, eclampsia/preeclampsia, acute renal failure, ventilation, uterine rupture, placenta
previa, unplanned hysterectomy (Kuriya et al., 2016; CDC, 2020).
The Code for the CDC events was as follows:

q

Code for the CDC events
q
q
q
q
q
q
q
q
q
q

if AcuteMI=1 then CDCEvent=1;
if Aneurysm=1 then CDCEvent=1;
if AcuteRF=1 then CDCEvent=1;
if AdultRespiratoryDS=1 then
CDCEvent=1;
if AmnioticFE=1 then CDCEvent=1;
if CardiacArrest=1 then CDCEvent=1;
if ConversionCR=1 then CDCEvent=1;
if DisseminatedIC=1 then CDCEvent=1;
if Eclampsia=1 then CDCEvent=1;
if HeartFailure=1 then CDCEvent=1;

38

q
q
q
q
q
q
q
q
q
q
q

if PuerperalCD=1 then CDCEvent=1;
if PulmonaryEdema=1 then
CDCEvent=1;
if AnesthesiaComplication=1 then
CDCEvent=1;
if Sepsis=1 then CDCEvent=1;
if Shock=1 then CDCEvent=1;
if SickleCell=1 then CDCEvent=1;
if Embolism=1 then CDCEvent=1;
if Transfusion=1 then CDCEvent=1;
if Hysterectomy=1 then CDCEvent=1;
if tracheostomy=1 then CDCEvent=1;
if Ventilation=1 then CDCEvent=1;

The table of International Classification of Diseases (ICD) diagnosis and procedure codes
used by the CDC identify delivery hospitalizations with SMM is available on the CDC website,
https://www.cdc.gov/reproductivehealth/maternalinfanthealth/smm/severe-morbidity-ICD.htm.

3.8

Data Analysis
SAS version 9.4 was used to analyze the data. Descriptive statistics tools were used to

summarize the data, including frequency, percentage, mean, standard deviation, cross-tabulations
to examine differences between groups, and chi-square and Wilcoxon-Mann-U test to explore
the significance of differences in results. Logistic regression was used to describe data and to
explain the relationship between independent variables and dependent variables.
We used The SURVEYFREQ Procedure to analyze deliveries by generation, controlling
for various variables, age, race, and comorbidity. The Charlson Comorbidity Index was used to
categorize and compare patients' comorbidities based on the pre-existing abstracted conditions
ICD codes.

3.9

Protection of Human Subjects/Ethical approval
The NIS data from the HCUP is de-identified and meets the criteria for non-human

research.
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4

CHAPTER IV: RESULTS

The study was a retrospective cohort study using the 2001 and 2016 data from the
Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project (HCUP)
outsourced from the Medical University of South Carolina. Due to the large dataset, practical
analysis of the data required the use of the large Comparative Effectiveness Data Analytics
Resources (CEDAR) workstations housed at the Medical University of South Carolina. The
study population included all women aged 20-35 years in 2001 (Generation X) and women at the
same age in 2016 (Millennials) who had childbirth (delivery) hospitalization regardless of the
outcome.
The outcomes of interest were as follows:
•

Differences in maternal risk factors (comorbidities)

•

Use of cesarean sections and induction of labor delivery methods

•

Adverse obstetrical outcomes (SMM indicators) as defined by the CDC

•

Length of stay (LOS), cost of admission (adjusted for inflation), and discharge

Overall, the analysis included 3,055,937 n(weighted) Millennial women (born 19811996) between 20 and 35 years-old in 2016 and 3,005,937 n(weighted) Generation X women
(born between 1965-1980) at the same age in 2001 who had delivery hospitalizations. 948,094
(31%) Millennial women were between 20-26 years old compared to 1,135,281 (37.8%)
Generation X women. Age group 26-30 comprised 1,125,259 (36.8%) Millennial women
compared to 1,033,045 (34.4%) Generation X. The final group, 31-35 years old had 983,584
(32.2%) Millennial women compared to 837,610 (27.9%) Generation X women.
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A substantial proportion of older women characterized millennial women, mean age 27.9
versus 27.2 for Generation X, increased length of hospital stay in days (2.6 versus 2.5), and a
significant proportion of women on Medicaid (43.2% versus 35.0%). The results also indicate
Millennial women were less likely to have private insurance, 50.6% versus 58.7%, and the same
was true for self-pay, 2.4% versus 3.2%.
The prevalence of cesarean delivery was higher among Millennial women 961,534
(31.5%) than Generation X women 740,453 (24.6). Millennials also had a higher comorbidity

score (0.07 versus 0.02). The results for induced labor indicated a higher rate for Millennial
women 1,128,759 (36.9%) than Generation X women 955,342 (31.8%).
Regarding severe maternal morbidity outcomes, findings revealed a higher proportion of
blood product transfusion, hysterectomy, infections, eclampsia, and acute renal failure for
Millennials versus Generation X.
Summary of results
q Overall, the analysis included:
q 3,055,937 Millennial women
q 3,005,937 Gen-X women
q Millennial women were characterized by:
q Older women, mean age 27.9 vs. 27.2
q Less likely to have private insurance,
50.6% vs.58.7
q More likely to have Medicaid
coverage, 43.2% vs. 35.0%
q Higher comorbidity score , 0.07 versus
0.02
q Longer LOS
q Lower total cost
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q Higher SMM events, including blood
product transfusion, hysterectomy,
infections, eclampsia, and acute renal
failure
q 1.32 (95% CI, 1.31 – 1.33) higher odds
of cesarean delivery
q Black women were 25% more
likely to have cesarean section than
white women; Hispanic 9%
q 1.28 (95%CI 1.27-1.29) higher odds of
induced labor
q Black women had a 23% reduced
chance of being induced than
White women, Hispanic women
33%

Additional descriptive statistics on the differences in maternal characteristics between
Millennial and Generation X women at the same age, 20-35, are included in Table 6.
Table 6. Demographics and study variables (weighted) stratified by birth generation.
Characteristics

Continuous Variables
Age in years
Length of Stay in days
Total Cost in dollars*
Charlson Score
Categorical Variables
Race
Black
Hispanic
Other
White
Age Group
20-25 years old
26-30 years old
31-35 years old
Died
Indication of Payor
Medicare
Medicaid
Private Insurance
Self-pay

Gen-X n=624,472
Millennial n=611,188
n(weighted)=3,005,937
n(weighted)=3,055,937
Demographic Variables
Mean (weighted) [95% CI]
27.2 [27.2-27.2]
27.9 [27.9-27.9]
2.5 [2.5-2.5]
2.6 [2.6-2.6]
4,999 [4,989-5,008]
4,868 [4,858-4,878]
0.02 [0.02-0.02]
0.07 [0.07-0.07]
N (weighted) (%)
261,930 (8.7)
510,779 (17.0)
1,052,465 (35.0)
1,180,763 (39.3)

427,765 (14.0)
574,484 (18.8)
500,650 (16.4)
1,553,038 (50.8)

1,135,281 (37.8)
1,033,045 (34.4)
837,610 (27.9)
131 (0.0)

948,094 (31.0)
1,124,259 (36.8)
983,584 (32.2)
145 (0.0)

10,849 (0.4)
1,050,159 (35.0)
1,760,127 (58.7)
95,815 (3.2)
Study Variables
N (weighted) (%)
740,453 (24.6)
955,342 (31.8)
1,257 (0.0)

23,220 (0.8)
1,317,934 (43.2)
1,544,593 (50.6)
72,590 (2.4)

Categorical Variables
Caesarian
961,534 (31.5)
Induction
1,128,759 (36.9)
Cardiovascular
630 (0.0)
Disease/Disorder
Acute Renal Failure
668 (0.0)
3,080 (0.1)
Acute Respiratory Disorders
1,018 (0.0)
2,920 (0.1)
Embolism
454 (0.0)
1,190 (0.0)
Disseminated Intravascular
4,162 (0.1)
5,075 (0.2)
Coagulation
Eclampsia
2,325 (0.1)
3,070 (0.1)
Pulmonary Edema
1,213 (0.0)
1,660 (0.1)
Severe Anesthesia
666 (0.0)
200 (0.0)
Complications
Infectious Disease/Disorder
1,128 (0.0)
5,230 (0.2)
Sickle Cell Disease with Crisis
304 (0.0)
420 (0.0)
Blood Products Transfusion
12,357 (0.4)
31,630 (1.0)
Hysterectomy
1,820 (0.1)
3,125 (0.1)
*Costs were weighted for Generation-X patients by multiplying total costs by factor of 1.7
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4.1

Differences by Cesarean Delivery
Table 7 uses an unweighted statistic to identify differences by cesarean delivery. A total

of 154,672 millennial women between the age of 20 and 35 in 2016 had cesarean delivery
compared to 128,792 Generation X women in the same age span in 2001. Millennial women
were more likely to be older, mean age 28.5 than Generation X women, mean age 27.9. The
length of stay for Millennials was lower than that of Generation X women.
Millennial women compared to Generation X women were more likely to have Medicaid
(44.2% versus 35.5%), and less likely to have private insurance (49.7% versus 58.4%). All
results were statistically significant, p<0.0001. The overall total cost for Millennials who
underwent cesarean delivery was lower than that of Generation X women, $6,528 ± 5,142 versus
7,440 ± 5,423, P<0.0001.
The rate of delivery hospitalization with one or more severe maternal morbidity as based
on CDC indicators was higher for Millennial women 2.7 n(unweighted=4,250) than Generation
X women 1.8 n(unweighted=2,283), p=<0.0001. The rest of the characteristics are as shown in
Table 2A.
Our logistic model (The SURVEYLOGISTIC Procedure) adjusted for age and race
showed Millennial women had 1.32 (95% CI, 1.31 – 1.33) higher odds of cesarean delivery at
the age of 20-35 years than Generation X women at the same age as shown in Table 2AA.
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Table 7. Sub-group

analysis of generational demographic differences by Cesarean delivery

Characteristics
Continuous Variables
Age in years
Length of Stay in days
Total Cost in dollars*
Charlson Score
Categorical Variables
Race
Black
Hispanic
Other
White
Age Group
20-25 years old
26-30 years old
31-35 years old
Died
Indication of Payor
Medicare
Medicaid
Private Insurance
Self-pay

Gen-X n=128,792
Millennial n=154,672
Demographic Variables
Mean ± (SD)
27.9 ± 4.3
28.5 ± 4.1
3.6 ± 3.0
3.3 ± 3.1
7,440 ± 5,423
6,528 ± 5,142
0.0 ± 0.2
0.1 ± 0.3
N (%)

p-value1

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

12,398 (9.6)
24,657 (19.1)
41,533 (32.2)
50,204 (39.0)

24,087 (15.6)
30,164 (19.5)
23,684 (15.3)
76,737 (49.6)
<0.0001

39,995 (31.1)
44,926 (34.9)
43,871 (34.1)
18 (0.0)

39,149 (25.3)
56,768 (36.7)
58,755 (38.0)
19 (0.0)

530 (0.4)
45,699 (35.5)
75,186 (58.4)
3,557 (2.8)
Study Variables

1,441 (0.9)
68,334 (44.2)
76,860 (49.7)
3,463 (2.2)

0.6954
<0.0001

Categorical Variables
N (%)
*CDC SMM
2,283 (1.8)
4,250 (2.7)
<0.0001
Indicator(s)
1Statistical Testing: All continuous variables were tested by the Wilcoxon-Mann-U test. Categorical
variables were tested by the Chi-Square test.
*Presence of one or more severe maternal morbidity (SMM) indicators as defined by CDC
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The odds for cesarean section for Black women were 25% higher than for white women,
while that of Hispanic women was 9% higher than for white women, as shown in Table 8.
Furthermore, Millennial women had 41% higher odds of comorbidities than Generation X
women.
Table 8. Cesarean deliveries for Millennials vs. Gen-X controlling for age and race analysis of
maximum likelihood estimates and odds ratio estimates – The SURVEYLOGISTIC procedure
Analysis of Maximum Likelihood Estimates

Parameter

Standar
d
Error t Value

Pr > |t|

-0.9235 0.00231 -400.38

<.0001

Estimate

Intercept
Generat

Mille

0.1381 0.00209

66.11

<.0001

Race2

Black

0.1670 0.00471

35.47

<.0001

Race2

Hispa

0.0232 0.00404

5.76

<.0001

Race2

Other

-0.1200 0.00377

-31.82

<.0001

AgeG

0

-0.2430 0.00296

-82.23

<.0001

AgeG

1

0.0106 0.00281

3.78

0.0002

0.3431 0.00870

39.43

<.0001

CharlsScore

Odds Ratio Estimates
Point
Estimate

Effect
Generat

95% Confidence Limits

Mille vs Gen-X

1.318 1.307

1.329

Race2

Black vs. White

1.268 1.251

1.284

Race2

Hispa vs. White

1.098 1.086

1.110

Race2

Other vs. White

0.951 0.942

0.961

AgeG

0 vs 2

0.622 0.615

0.628

AgeG

1 vs. 2

0.801 0.794

0.809

1.409 1.385

1.434

CharlsScore

NOTE: The degrees of freedom in computing the confidence limits is 1235659.
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4.2

Differences by Induction of Labor
Table 2B shows our sub-group analysis of generational demographic differences by

Induction delivery. More Millennials than Generation X women had used induction of labor,
n=188,117 versus n=172,166. The mean age for Millennial women was higher than Generation
X women 27.6 ± 4.2 versus 27.1 ± 4.4 p <0.0001. Millennial women had the highest (37%)
proportion of induction among the 26-30-year-old group and the lowest (29.7%) among the 3135-year-old group.
In contrast, Generation X women rate of induced labor declined with increased age group
(20-25 =39%, 26-30=34%, and 31-35 = 26.6%). The total cost of induction of labor
hospitalization was lower for Millennials $4,125 ± 2,727 versus 4,239 ± 2,686 for Generation X,
despite Millennials having a longer length of stay (days) and higher comorbidity score, 2.3 ± 1.4
versus 2.1 ± 1.4, and 0.1 ± 0.3 versus 0.0 ± 0.2, respectively. Millennials who had induction of
labor were more likely to have SMM events than Generation X women, 1,721 (0.9) versus 820
(0.5), p<0.0001.
Women with private insurance were more likely to be induced, 51.9% for Millennials
versus 62.1% for Generation X women (p<0.0001). At the same time, those with Medicaid
ranked second in induced labor, 41.8% for Millennials versus 31.9% Generation X women, as
shown in Table 9.
The rest of the statistical analysis is, as shown in Table 9.
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Table 9. Generational Demographic Differences by Induction Delivery

Characteristics

Gen-X n=172,166

Demographic Variables
Continuous Variables
Age in years
Length of Stay in days
Total Cost in dollars*
Charlson Score
Categorical Variables

Mean ± (SD)
27.1 ± 4.4
2.1 ± 1.4
4,239 ± 2,686
0.0 ± 0.2
N (%)

Race
Black
Hispanic
Other
White
Age Group
20-25 years old
26-30 years old
31-35 years old
Indication of Payor
Medicare
Medicaid
Private Insurance
Self-pay
Study Variables
Categorical Variables
*CDC Event

Millennial
n=188,117

p-value1

27.6 ± 4.2
2.3 ± 1.4
4,125 ± 2,727
0.1 ± 0.3

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

12,746 (7.4)
22,994 (13.4)
62,883 (36.5)
73,543 (42.7)

23,311 (12.4)
31,282 (16.6)
30,207 (16.1)
103,317 (54.9)
<0.0001

67,192 (39.0)
59,260 (34.4)
45,714 (26.6)

62,480 (33.2)
69,688 (37.0)
55,949 (29.7)

534 (0.3)
54,837 (31.9)
106,911 (62.1)
4,542 (2.6)

1,371 (0.7)
78,607 (41.8)
97,711 (51.9)
4,045 (2.2)

<0.0001

N (%)
820 (0.5)

1,721 (0.9)

<0.0001

1Statistical Testing: All continuous variables were tested by the Wilcoxon-Mann-U test. Categorical variables were tested by the
Chi-Square test.
*Presence of one or more severe maternal morbidity (SMM) indicators as defined by CDC

47

Table 10 shows our logistic model analysis of induction of labor for Millennial women versus
Generation X women, controlling for Age, Race, Comorbidity. Millennial women had 1.28 (95%CI 1.271.29) higher odds of being induced than Generation X women. Black women had a 23% reduced chance
of being induced than White women and Hispanic women 33% reduced chances of being induced than
White women. The odds of comorbidity for Millennials was 5% higher than that of Millennials.

Table 10. Induction Deliveries for Millennials vs. Gen-X controlling for age and race analysis of
maximum likelihood estimates and odds ratio estimates – The SURVEYLOGISTIC procedure
Analysis of Maximum Likelihood Estimates
Standard
Estimate
Error t Value

Parameter
Intercept

Pr > |t|

-0.7242

0.00225

322.20

<.0001

0.00197

62.22

<.0001

Generat

Mille

0.1227

Race2

Black

-0.0796

0.00466 -17.07

<.0001

Race2

Hispa

-0.2193

0.00399 -55.00

<.0001

Race2

Other

0.1151

0.00353

32.56

<.0001

AgeG

0

0.0861

0.00270

31.83

<.0001

AgeG

1

0.00843

0.00266

3.16

0.0016

0.0512

0.00806

6.36

<.0001

CharlsScore

NOTE: The degrees of freedom for the t-tests is 1235659.
Odds Ratio Estimates
Effect
Generat

Mille vs. Gen-X

Point Estimate

95% Confidence Limits

1.278

1.268

1.288

Race2

Black vs. White

0.768

0.759

0.778

Race2

Hispa vs. White

0.668

0.661

0.675

Race2

Other vs. White

0.934

0.925

0.942

AgeG

0 vs 2

1.198

1.187

1.209

AgeG

1 .vs 2

1.108

1.098

1.119

1.053

1.036

1.069

CharlsScore

NOTE: The degrees of freedom in computing the confidence limits is 1235659.
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4.3

Differences by Induction and Cesarean Delivery

Table C shows the analysis of the differences by induction and cesarean delivery based
on unweighted data. A total of 37,635 Millennial women had an induction with cesarean delivery
compared to 25,269 Generation X women at the same age, 20-35. Millennial women compared
to Generation X were older women (mean age 27.8 versus 27.5, p<0.0001) with a higher
comorbidity score, 0.1 ± 0.3 versus 0.0 ± 0.2, p<0.0001.
While the average length of stay in days was comparable, 3.9 days, Millennials had a
higher proportion of SMM events, 3.2 (1,211) compared to 1.6 (394). However, the total cost of
hospitalization for Millennial women was lower $7,701 ± 4,770 versus $8,451 ± 4,540.
The age group 26-30 had the highest proportion of induction and cesarean, 13,772 (36.6)
for Millennials versus 8,996 (35.6), p<0.0001 for Generation X women, as indicated in Table 11.
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Table 11. Analysis of demographic differences by Induction with Cesarean - delivery

Characteristics
Continuous
Variables
Age in years
Length of Stay in
days
Total Cost in dollars*
Charlson Score
Categorical
Variables
Race
Black
Hispanic
Other
White
Age Group
20-25 years old
26-30 years old
31-35 years old
Indication of Payor
Medicare
Medicaid
Private Insurance
Self-pay
Categorical
Variables
*CDC Event

Gen-X n=25,269
Millennial n=37,635
Demographic Variables
Mean ± (SD)

p-value1

27.5 ± 4.4
3.9 ± 2.4

27.8 ± 4.3
3.9 ± 2.2

<0.0001
<0.0001

8,451 ± 4,540
0.0 ± 0.2

7,701 ± 4,770
0.1 ± 0.3
N (%)

<0.0001
<0.0001

<0.0001
2,309 (9.1)
3,287 (13.0)
9,382 (37.1)
10,291 (40.7)

6,286 (16.7)
6,266 (16.6)
6,151 (16.3)
18,932 (50.3)
<0.0001

8,628 (34.1)
8,996 (35.6)
7,645 (30.3)

12,018 (31.9)
13,772 (36.6)
11,845 (31.5)
<0.0001

98 (0.4)
301 (0.8)
6,960 (27.5)
14,810 (39.4)
16,991 (67.2)
20,727 (55.1)
511 (2.0)
757 (2.0)
Study Variables
N (%)
394 (1.6)

1,211 (3.2)

<0.0001

1Statistical Testing: All continuous variables were tested by the Wilcoxon-Mann-U test. Categorical variables were tested by the Chi-Square
test.
*Presence of one or more severe maternal morbidity (SMM) indicators as defined by CDC
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5

5.1

CHAPTER V: DISCUSSION

Discussion of Results

The analysis used data from the National Inpatient Sample (NIS) from the Healthcare Cost
and Utilization Project for the years 2001 and 2016 to explore differences in induction of labor
and cesarean delivery for Generation X (born between 1965 and 1980) and Millennial (born
between 1981-1996) women aged 20-35 years in each year respectively.
We compared characteristics of women aged group 20-35 -years-old to minimize the effect
of the independent risk factor of age. Evidence shows ages under 20- years old and over 35years-old are independent risk factors for adverse maternal outcomes (Walker et al., 2020).
Overall, our data demonstrated that Millennial women were more likely to be older, have
higher comorbidities, higher prevalence of severe maternal morbidity (SMM), and longer length
of stay. Furthermore, Millennial women compared to Generation X women were more likely to
have Medicaid as their primary payor, less likely to have private insurance, and more likely to
have lower overall hospital costs. Further discussion related to outcomes of interest follows
below:

5.1.1

Differences in the presence of maternal risk factors

Age, race/ethnicity, insurance, and pre-existing conditions are common maternal risk
factors for adverse outcomes. To improve outcomes, deliberate efforts to mitigate these factors
are needed. The finding of Millennial women being older than Generation X women was
expected and is consistent with evidence from other studies and the data from the National Vital
Statistics System, which shows a rise in the mean age of mothers at first birth from 24.9 years in
2000 to 26.3 years in 2014 (Mathews & Hamilton, 2016).
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Increased maternal age is consistently linked to increases in pre-pregnancy risk factors that
may impact pregnancy outcomes (Burgess et al., 2020; Luke et al., 2019; Mogos et al., 2020;
Rydahl et al., 2019). Furthermore, literature examining the impact of advanced maternal age on
outcomes has consistently found it to be an independent risk factor for gestational diabetes,
preeclampsia, placenta previa, low birth weight (less than 2500 g), and preterm births (Marozio
et al., 2019).
Millennials at the same age as Generation X may require a more focused care approach to
prevent adverse outcomes. Understanding generation-specific factors that influence delayed
motherhood may also be necessary to minimize adverse maternal outcomes associated with age.
Overall, our data revealed a lower proportion of Millennial women compared to Generation
X women with private insurance, 50.6% versus 58.7%. This finding was unexpected because we
expected the expanded health insurance coverage under the Affordable Care Act (ACA), which
allows children under 26 to remain on their parents’ insurance policy (French et al., 2016), to
work in favor of Millennials. One characteristic that makes Millennials different from other
generations is that they grew up in a different health policy environment influenced mainly by
the ACA (DePew, 2019).
The plausible explanation for the lower rate of Millennials with private insurance despite
expanded coverage provided by the ACA may be explained by the fact that Millennials are
delaying motherhood. Most Millennials are becoming mothers for the first time at a mean age of
26.3 years (Mathews & Hamilton, 2016), which is past the age they can remain on their parents'
insurance policies. Our data shows a higher mean age for Millennials, 27.9% compared to
Generation X 27.2%. It may be helpful for future studies to compare induced labor and cesarean
delivery by Millennials aged less than 26-years old and those over 26 years old. The other
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plausible explanation may be that more Millennials are shunning private insurance because of
higher insurance deductibles.
However, our analysis revealed a higher proportion of Millennials on Medicaid 43.2%
versus Generation X women 35.0%, which may indicate that more Millennials benefit from the
ACA's Medicaid expansion. Our subgroup analysis by procedure type, cesarean delivery, and
labor induction revealed a similar pattern in insurance coverage. 49.7% of Millennial women
with private insurance had cesarean delivery compared to 58.4% Generation X women.
Overall, our data showed that having private insurance was associated with cesarean
delivery and induction of labor across generations. The financial incentives private insurance
offers providers may influence this trend. An effective review of the necessity for procedures
may reduce severe maternal morbidity or complications associated with cesarean delivery.

5.1.2

Differences in the use of cesarean delivery and induction of labor
The analysis found the prevalence of cesarean delivery was higher among Millennial women than

Generation X women. Women in the age group 31-35 years old were 38% more likely to have a cesarean
section than women in the age group 20-25 and 20% more likely than women in the 26-30 age group.
Black women were 27% more likely to have a cesarean delivery than white women, Hispanic women 9%
more likely than white women, and other races 5% less likely than white women.

The results on induction of labor indicated a higher rate for Millennial women (36.9%) than
Generation X women (31.8%). Black women across generations were 23% less likely to be
induced than white women, Hispanic 33% less likely, and other race 7 % less likely. Our subgroup analysis of generational demographic differences by induction of labor and race shows k
Millennial black women had a 5 percent increase in the rate of induction over Generation X
women. In contrast, Millennial white women had a 12 percent increase over Generation X white
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women.
The racial and ethnic disparities in the induction of labor are particularly concerning
because growing evidence now links induction of labor in low-risk singleton pregnancies at term
and beyond with decreased risks of cesarean delivery or perinatal adverse events, and reduced
risk of gestational hypertensive diseases (Caughey et al., 2009; Saccone et al., 2019; Sotiriadis
et al., 2019).
Since evidence suggests black women are at a higher risk for adverse maternal outcomes
than other races (Burgess et al., 2020; Howell et al., 2020) (Aziz et al., 2019), more needs to be
done to ensure lifesaving obstetric interventions reach the target population.
Our data also found that Millennial women had the highest (37%) rate of induction among
the 26-30-year-old group and the lowest (29.7%) among the 31-35-year-old group. This finding
may confirm that most inductions by Millennial women are elective because evidence shows that
most pregnancy complications are associated with advanced maternal age.
The rate of induction of labor among Generation X women declined with increased age
group (20-25 =39%, 26-30=34%, and 31-35 = 26.6%). The reason for this pattern is not clear.

5.1.3

Differences in adverse obstetrical outcomes defined by CDC indicators
Our data revealed that Millennial women compared to Generation X women had a higher

prevalence of severe maternal morbidity (SMM), 0.9 versus 0.5, p<0.01, including blood product
transfusion, hysterectomy, infections, eclampsia, and acute renal failure.
The prevalence of one or more SMM (CDC events) was more significant in women with cesarean
delivery, 3.2% for Millennial women versus1.6% for Generation X women. The findings support
evidence from our literature review, which indicates that cesarean delivery in low-risk pregnancies is
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a risk factor for severe maternal morbidly (Clark et al., 2008; Leonard, Main, & Carmichael,
2019). Providers may do well to reduce the number of elective cesarean deliveries to minimize
the risk of adverse maternal outcomes.
Several factors may be responsible for the increase in SMM among Millennial women, including
increased pre-existing comorbidities, 0.07 versus 0.02, as measured by the Charlson Comorbidity score.
The Charlson Comorbidity Index scale is a weighted index scale that accounts for the presence and
seriousness of health conditions, including myocardial infarction, diabetes mellitus, congestive heart
failure, cerebrovascular disease, and chronic pulmonary disease to predict the one-year mortality rate of a
patient (Charlson et al., 1987).

The fact that Millennial women are older, and most of them have Medicaid insurance may
be a contributing factor to an increase in SMM. Evidence associates advanced age, Medicaid, or
no insurance coverage is associated with a higher risk for adverse maternal outcomes, including
deaths from cardiovascular, respiratory, and sepsis-related conditions (Wang et al., 2020).

5.1.4

Differences in length of stay (LOS), cost of admission (adjusted for inflation), and discharge
destination.

Although Millennial women had higher comorbidity factors, higher prevalence of
SMM, and longer length of stay than Generation X women, their total cost was surprisingly
lower than of Generation X women. We found the overall total cost for Millennials who
underwent cesarean delivery was lower than that of Generation X women, $ 6,528 ± 5,142 versus
7,440 ± 5,423, P<0.0001.

We think the fact that Millennial women compared to Generation X women were more
likely to have Medicaid (44.2% versus 35.5%), and less likely to have private insurance (49.7%
versus 58.4%) may explain the lower total costs. Furthermore, the reduced length of stay for
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Millennials 3.3 ± 3.1 versus 3.6 ± 3.0, p <0.0001 for women who had a cesarean delivery, may
have contributed to the lower cost.

5.2

Summary

To the best of our knowledge, our study is the first to examine generational-specific
differences in induced labor and cesarean delivery between Millennial and Generation X women
at precisely the same age using the same variables. Our analysis found evidence of increased
rates of cesarean delivery and induced labor even after controlling for age, race, and comorbidity
factors among Millennial women. This means obstetric interventions, labor induction, and
cesarean delivery may be routinely performed without indications. The findings offer a plausible
explanation of why a rapid increase in induced labor and cesarean delivery shows no
corresponding evidence of decreasing maternal and neonatal morbidity.
We also found that Millennials are less likely to have private insurance and more likely to
have Medicaid coverage than Generation X. The more substantial proportion of Millennials with
Medicaid is concerning as several studies have associated public insurance coverage with poor
outcomes. An effective quality review process of the care provided to patients with public
insurance may mitigate adverse outcomes.
Finally, we established that Millennial women had increased comorbidities, severe
maternal morbidity, and increased length of hospital stay than Generation X. To our surprise,
these factors did not translate into a higher cost of hospitalization related to lower reimbursement
rates by Medicaid.

56

5.3

Limitations/Future Studies

Our study has several weaknesses and limitations. First, it’s crucial to establish that the
main focus of our analysis was to determine differences in the demographic and clinical
characteristics between Millennial and Generation X women associated with the use of induced
labor and cesarean delivery procedure. As a result, we did not primarily focus on determining
causation.
Second, our study did not control for individual patient’s existing conditions in determining
risk factors. Instead, we used the Charlson Comorbidity index scale that includes some of the
variables that are not particularly relevant to maternal health. Future studies may wish to explore
the impact of individual conditions to identify conditions that may be responsible for higher rates
of induction and cesarean procedures among Millennials.
Third, our study used archival data, which limits the kind of analysis that can be done on
the available variables or elements. The analysis was limited by the availability and accuracy of
the coded variables. For example, we needed to compare outcomes of interest by median income,
region, and hospital type, but we could not find data for Generation X women. Also, the archival
data used was drawn from two different datasets that were coded differently. The 2001 data was
coded using ICD 9, whereas the 2016 dataset was coded using ICD 10.
Fourth, our study did not identify generation-specific behaviors/attitudes that influence
treatment preferences. Future studies may wish to explore generational-specific practices that
affect choices of individual obstetric interventions.
Finally, the study did not compare indications for induced labor/cesarean delivery based on
ACOG recommendation for the two groups, a critical focus for future research to help identify
changes in indications associated with various obstetric interventions.
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5.4

Conclusion

Despite some limitations, our study reveals the importance of recognizing generationalspecific changes in maternal characteristics that may influence access to care, care preferences,
and outcomes. As Millennial women now account for the vast majority of all US childbirths,
exploring maternal health characteristics specific to Millennials is necessary to recognize
potential trends and opportunities for improvement. Taking care of Millennial women and
improving their maternal outcomes will require multifaceted approaches, including
implementation of policies that reduce barriers to access, promote equity, and preventative care.
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